General Information of the Compound
| Compound ID |
CP0909342
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(5-methyl-4-(4-(5-(pyridin-3-yl)oxazol-2-yl)piperazine-1-carbonyl)-1H-pyrazol-1-yl)pyrrolo[1,2-f][1,2,4]triazin-4(3H)-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H21N9O3
|
||||||||||||||||||
| Molecular Weight |
471.481
|
||||||||||||||||||
| Canonical SMILES |
Cc1c(C(=O)N2CCN(c3ncc(-c4cccnc4)o3)CC2)cnn1-c1nn2cccc2c(=O)[nH]1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H21N9O3/c1-15-17(13-26-32(15)22-27-20(33)18-5-3-7-31(18)28-22)21(34)29-8-10-30(11-9-29)23-25-14-19(35-23)16-4-2-6-24-12-16/h2-7,12-14H,8-11H2,1H3,(H,27,28,33)
Show/Hide
|
||||||||||||||||||
| InChIKey |
YGVFXEOUMBAWQM-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound